Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMC 508356)

Published in J Clin Invest on October 01, 1997

Authors

E Chaves-Olarte1, M Weidmann, C Eichel-Streiber, M Thelestam

Author Affiliations

1: Microbiology and Tumorbiology Center (MTC), Karolinska institutet, S-171 77 Stockholm, Sweden.

Articles citing this

Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69

Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun (2001) 1.85

p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest (2000) 1.68

The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest (1999) 1.52

The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell (2000) 1.38

Toward a structural understanding of Clostridium difficile toxins A and B. Front Cell Infect Microbiol (2012) 1.22

Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect Immun (2006) 1.07

Yersinia enterocolitica adhesin A induces production of interleukin-8 in epithelial cells. Infect Immun (2004) 1.04

A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model. Clin Vaccine Immunol (2013) 1.03

Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc Natl Acad Sci U S A (2013) 1.02

Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect Immun (2014) 1.01

Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J Biol Chem (2012) 0.99

Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99

In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B. Infect Immun (2013) 0.98

Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc Natl Acad Sci U S A (2015) 0.97

Cloning, expression and characterization of a mammalian Nudix hydrolase-like enzyme that cleaves the pyrophosphate bond of UDP-glucose. Biochem J (2003) 0.95

Protective efficacy induced by recombinant Clostridium difficile toxin fragments. Infect Immun (2013) 0.94

A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity. PLoS One (2013) 0.93

Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect Immun (2012) 0.92

Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin. Exp Cell Res (2009) 0.88

Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis. Infect Immun (2014) 0.86

Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile. Antimicrob Agents Chemother (2008) 0.86

Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models. Gut Microbes (2014) 0.85

Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins. Future Microbiol (2010) 0.85

Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile. MBio (2015) 0.83

Signaling involved in neurite outgrowth of postnatally born subventricular zone neurons in vitro. BMC Neurosci (2010) 0.83

Clostridium sordellii lethal toxin is maintained in a multimeric protein complex. Infect Immun (2004) 0.82

Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control. BMC Syst Biol (2012) 0.82

Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis. Gut Microbes (2015) 0.80

Ileal smooth muscle motility depression on rabbit induced by toxin A from Clostridium difficile. Dig Dis Sci (2008) 0.78

High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types. BMC Microbiol (2015) 0.78

Biophysical Characterization and Activity of Lymphostatin, a Multifunctional Virulence Factor of Attaching and Effacing Escherichia coli. J Biol Chem (2016) 0.77

Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel) (2016) 0.77

The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins. Toxins (Basel) (2015) 0.77

Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B. Toxins (Basel) (2016) 0.77

Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms. Infect Immun (2016) 0.75

Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities. Infect Immun (2016) 0.75

Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue. J Struct Biol (2017) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08

Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44

Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest (1988) 3.12

The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem (1995) 3.02

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest (1995) 2.91

Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol (1996) 2.85

Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology (1994) 2.28

Association of diphtheria toxin with Vero cells. Demonstration of a receptor. J Biol Chem (1978) 2.13

Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet (1992) 2.00

Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem (1997) 1.83

Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol Microbiol (1995) 1.81

Bacterial toxins that target Rho proteins. J Clin Invest (1997) 1.69

Toxin A of Clostridium difficile is a potent cytotoxin. J Clin Microbiol (1990) 1.65

Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology (1992) 1.62

Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile. J Med Microbiol (1992) 1.47

Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. Microb Pathog (1987) 1.45

Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J Biol Chem (1996) 1.39

Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb Pathog (1986) 1.34

Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun (1992) 1.32

Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. Biochim Biophys Acta (1983) 1.23

Cellular internalisation of Clostridium difficile toxin A. Microb Pathog (1987) 1.20

Monoglucosylation of low-molecular-mass GTP-binding Rho proteins by clostridial cytotoxins. Trends Cell Biol (1995) 1.14

UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii. J Biol Chem (1996) 1.04

Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters. Infect Immun (1991) 0.97

Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology (1996) 0.96

Clostridium difficile toxins attack Rho. Trends Microbiol (1996) 0.91

An improved radiochemical assay for uridine diphosphoglucose pyrophosphorylase. Anal Biochem (1976) 0.82

Microfilament-disrupting Clostridium difficile toxin B causes multinucleation of transformed cells but does not block capping of membrane Ig. Eur J Cell Biol (1990) 0.80

Articles by these authors

Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol (1996) 2.85

Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25

Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts. Infect Immun (1975) 1.78

Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture. Scand J Infect Dis Suppl (1980) 1.68

The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem (2000) 1.64

A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem (1999) 1.58

Clostridium difficile toxin A and its effects on cells. Toxicon (1991) 1.54

Effects of staphylococcal alpha-, beta-, delta-, and gamma-hemolysins on human diploid fibroblasts and HeLa cells: evaluation of a new quantitative as say for measuring cell damage. Infect Immun (1973) 1.54

The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest (1999) 1.52

Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864--implications for transcription, expression and enzymatic activity of toxins A and B. Mol Gen Genet (1998) 1.49

Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood (2000) 1.48

Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J Biol Chem (1996) 1.39

Determination of toxin-induced leakage of different-size nucleotides through the plasma membrane of human diploid fibroblasts. Infect Immun (1975) 1.39

Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb Pathog (1986) 1.34

Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34

GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27

Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect Immun (2000) 1.24

Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. Biochim Biophys Acta (1983) 1.23

Cellular internalisation of Clostridium difficile toxin A. Microb Pathog (1987) 1.20

Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin. Infect Immun (1981) 1.19

Classification of microbial, plant and animal cytolysins based on their membrane-damaging effects of human fibroblasts. Biochim Biophys Acta (1979) 1.19

The intrinsic ability of ribosomes to bind to endoplasmic reticulum membranes is regulated by signal recognition particle and nascent-polypeptide-associated complex. Proc Natl Acad Sci U S A (1995) 1.17

Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene. J Biol Chem (1997) 1.17

The projection structure of perfringolysin O (Clostridium perfringens theta-toxin). FEBS Lett (1993) 1.13

Toxinogenicity of clinical isolates of coagulase-negative staphylococci towards various animal cells. Acta Pathol Microbiol Scand B (1981) 1.07

The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon (2001) 1.06

Cytotoxic effects on the plasma membrane of human diploid fibroblasts--a comparative study of leakage tests. Med Biol (1976) 1.06

Sandfly fever virus activity in central/northern Anatolia, Turkey: first report of Toscana virus infections. Clin Microbiol Infect (2010) 1.04

UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii. J Biol Chem (1996) 1.04

The projection structure of alpha-toxin from Staphylococcus aureus in human platelet membranes as analyzed by electron microscopy and image processing. J Ultrastruct Mol Struct Res (1988) 1.02

Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene. Eur J Biochem (2000) 1.02

Effect of Clostridium perfringens phospholipase C(alpha-toxin) on the human diploid fibroblast membrane. J Membr Biol (1974) 1.01

The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. Microb Pathog (2001) 1.01

A new approach for diagnosis of bovine coronavirus using a reverse transcription recombinase polymerase amplification assay. J Virol Methods (2013) 0.99

Membrane-damaging and cytotoxic effects on human fibroblasts of alpha- and beta-hemolysins from Aeromonas hydrophila. Infect Immun (1981) 0.99

Electrophoretic and immunochemical studies of Micrurus snake venoms. Toxicon (1994) 0.97

Interaction of streptolysin O from Streptococcus pyogenes and theta-toxin from Clostridium perfringens with human fibroblasts. Infect Immun (1980) 0.94

The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. J Am Acad Dermatol (2001) 0.93

Survival of cultured cells after functional and structural disorganization of plasma membrane by bacterial haemolysins and phospholipases. Toxicon (1983) 0.91

Oligomerization of 3H-labelled staphylococcal alpha-toxin and fragments on adrenocortical Y1 tumour cells. Microb Pathog (1988) 0.90

Photolabeling of staphylococcal alpha-toxin from within rabbit erythrocyte membranes. Biochem Biophys Res Commun (1983) 0.90

Clostridium difficile toxin A elicits Ca(2+)-independent cytotoxic effects in cultured normal rat intestinal crypt cells. Infect Immun (1993) 0.89

A staphylococcal alpha-toxin fragment. Its characterization and use for mapping biologically-active regions of alpha-toxin. Acta Pathol Microbiol Immunol Scand B (1986) 0.88

Membrane-damaging action of alveolysin from Bacillus alvei. Infect Immun (1981) 0.88

ADP-ribosylation in cultured cells treated with Clostridium difficile toxin B. Biochem Biophys Res Commun (1986) 0.87

Loss of surface fibronectin from human lung fibroblasts exposed to cytotoxin from Clostridium difficile. Infect Immun (1983) 0.87

Divergent roles for Ras and Rap in the activation of p38 mitogen-activated protein kinase by interleukin-1. J Biol Chem (2000) 0.87

Dithiothreitol generates an activated 250,000 mol. wt form of Clostridium difficile toxin B. Toxicon (1993) 0.86

Two different modes of membrane damaging action by bacterial thiol-activated haemolysins. Toxicon (1982) 0.86

Extravasation of staphylococcal alpha-toxin in normal and injured CNS regions lacking blood-brain barrier function: observations after ventral root replantation. Brain Res (1991) 0.86

The lysis of human diploid fibroblasts with borate buffer. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.86

Early events in the action of staphylococcal alpha-toxin on the plasma membrane of adrenocortical Y1 tumor cells. Infect Immun (1986) 0.85

Characterization of multiple nicotinic acetylcholine receptor-binding proteins and phospholipases A2 from the venom of the coral snake Micrurus nigrocinctus. FEBS Lett (1996) 0.85

UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J Biol Chem (1998) 0.85

Characterization of domain borders and of a naturally occurring major fragment of staphylococcal alpha-toxin. FEBS Lett (1987) 0.84

Crystalline layers and three-dimensional structure of Staphylococcus aureus alpha-toxin. J Mol Biol (1990) 0.84

Modulation of granulocyte functions by bacterial exotoxin and endotoxins. Immunology (1987) 0.84

Membrane damage by staphylococcal alpha-toxin to different types of cultured mammalian cell. Biochim Biophys Acta (1983) 0.84

Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities. Arch Biochem Biophys (2000) 0.84

Cultured human fibroblasts as a model for evaluation of potential in vivo toxicity of membrane damaging antibiotics. Chem Biol Interact (1980) 0.83

Activation of cellular phospholipase A2 by Clostridium difficile toxin B. J Cell Biochem (1993) 0.83

Clostridium difficile toxin A induces multinucleation in the human leukemic T cell line JURKAT. Eur J Cell Biol (1992) 0.83

Elapid venom toxins: multiple recruitments of ancient scaffolds. Eur J Biochem (1999) 0.83

Oligomer formation of staphylococcal alpha-toxin analyzed by electron microscopy and image processing. FEMS Microbiol Immunol (1992) 0.82

The three-dimensional structure of trypsin-treated Staphylococcus aureus alpha-toxin. J Struct Biol (1993) 0.82

The interaction of phospholipase C from Staphylococcus aureus and Clostridium perfringens with cell membranes. J Hyg Epidemiol Microbiol Immunol (1974) 0.81

Two membrane damaging toxins from Aeromonas hydrophila. Toxicon (1982) 0.81

Delineation of the catalytic domain of Clostridium difficile toxin B-10463 to an enzymatically active N-terminal 467 amino acid fragment. FEMS Microbiol Lett (1997) 0.81

Microfilament-disrupting Clostridium difficile toxin B causes multinucleation of transformed cells but does not block capping of membrane Ig. Eur J Cell Biol (1990) 0.80

Distribution of 3H-labeled staphylococcal alpha-toxin and a toxin fragment in mice. Infect Immun (1987) 0.80

Effects of Bothrops asper (terciopelo) myotoxin III, a basic phospholipase A2, on liposomes and mouse gastrocnemius muscle. Toxicon (1993) 0.79

Calcium and calmodulin in cellular intoxication with Clostridium difficile toxin B. J Cell Physiol (1987) 0.79

Assay of pore-forming toxins in cultured cells using radioisotopes. Methods Enzymol (1988) 0.78

Staphylococcus aureus alpha-toxin: characterization of protein/lipid interactions, 2D crystallization on lipid monolayers, and 3D structure. J Struct Biol (1997) 0.78

ADP-ribosylation in Clostridium difficile toxin-treated cells is not related to cytopathogenicity of toxin B. Biochim Biophys Acta (1991) 0.78

Polyphosphate-mediated protection from cellular intoxication with Clostridium difficile toxin B. Biochim Biophys Acta (1984) 0.77

Development of immunoassays for determination of circulating venom antigens during envenomations by coral snakes (Micrurus species). Toxicon (1997) 0.77

Effect of Bothrops asper (Fer-De-Lance) snake venom on erythrocyte membrane. A comparative study. Comp Biochem Physiol C (1992) 0.76

Venom of the crotaline snake Atropoides nummifer (jumping viper) from Guatemala and Honduras: comparative toxicological characterization, isolation of a myotoxic phospholipase A(2) homologue and neutralization by two antivenoms. Comp Biochem Physiol C Toxicol Pharmacol (2001) 0.76

Evaluation of the biological activity of cigarette-smoke condensate fractions using six in vitro short-term tests. J Toxicol Environ Health (1984) 0.75

Signal transduction pathways and cellular intoxication with Clostridium difficile toxins. J Cell Biochem (1993) 0.75

The influence of meteorological factors on children and youths: a 10 per cent random selection of 16000 pupils and apprentices of Basle City (Switzerland). Acta Paedopsychiatr (1974) 0.75

The culture of youth and drug abuse in some European countries. Int J Addict (1976) 0.75

[What is the progress in angiology with calcitonin (CT) and calcitonin-gene related peptide (CGRP)? Relations to vascular tonus?]. Vasa Suppl (1991) 0.75

Cytopathogenic effects of atoxyl, an ototoxic compound, on human diploid fibroblasts in vitro. Chem Biol Interact (1977) 0.75

[Distribution of methadone in blood, cerebrospinal fluid, urine and organ tissues]. Beitr Gerichtl Med (1991) 0.75

Management of solitary melanoma metastasis of the brain. Aust N Z J Surg (1989) 0.75

Hydrophobicity of cultured mammalian cells and some effects of bacterial phospholipases C. Acta Pathol Microbiol Immunol Scand B (1984) 0.75

[Drug consumption by Basel school children--an epidemiologic study]. Schweiz Med Wochenschr (1973) 0.75

Spectrophotometric evaluation of streptomycetes pigments. Ann Med Exp Biol Fenn (1966) 0.75

The structure of Staphylococcus aureus alpha-toxin: effects of trypsin treatment. J Struct Biol (1991) 0.75

[Intravenous drug administration and hepatitis among young people in Basel]. Schweiz Med Wochenschr (1974) 0.75

Bacterial protein toxins--general conclusions. Int J Med Microbiol (2000) 0.75

Screening and characterization of membrane damaging effects in tissue culture. Toxicology (1980) 0.75

Effect of tobacco smoke compounds on the plasma membrane of cultured human lung fibroblasts. Toxicology (1980) 0.75

On the mode of action ofClostridium difficile toxin A: anin vitro study. Cytotechnology (1991) 0.75

[A treatment possibility of arterial occlusive diseases with calcitonin. Retrospect of 16 years experience in over 200 patients between 20 and 99 years of age]. Vasa Suppl (1988) 0.75

[Treatment, follow-up and prognosis of drug addiction (author's transl)]. Dtsch Med Wochenschr (1976) 0.75

Significance of polyene compounds as taxonomic criteria in streptomycetes. Ann Med Exp Biol Fenn (1967) 0.75